40 results
8-K
EX-99.2
PROK
ProKidney Corp - Ordinary Shares
10 Jun 24
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
8:00am
) (n=49) Hematoma 2 1 Thrombosis 1 0 Hematuria 1 0 Hydronephrosis 1 0 Death 0 0 Acute Kidney Injury 2 0 22 Data as of May 7, 2024
REGEN-007 Interim
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
29 May 24
RMCL-002 Final Analysis Developing Solutions for Dialysis Prevention May 2024
7:04am
# of events (n=83)* RILPARENCEL INJECTION # of events (n=132)* Hematoma (including Page Kidney during biopsy) 2 2 Pain 0 2 Acute Kidney Injury 1 1 CKD
8-K
EX-10.1
PROK
ProKidney Corp - Ordinary Shares
25 Mar 24
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
4:07pm
by you (whether or not related to your relationship with the Company); (ii) an act of moral turpitude by you, or any act that causes significant injury
8-K/A
EX-10.1
PROK
ProKidney Corp - Ordinary Shares
18 Mar 24
Departure of Directors or Certain Officers
4:09pm
by Executive of any claims for breach of contract, wrongful discharge and all claims for alleged physical or personal injury, emotional distress relating
8-K/A
EX-10.2
kgd56u3j6
18 Mar 24
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
vckg20ddonzar
26 Jan 24
Regulation FD Disclosure
12:00am
8-K/A
EX-10.1
7zr56426vtka
5 Dec 23
Departure of Directors or Certain Officers
4:06pm
8-K
EX-99.1
idwu c3g7
13 Nov 23
Departure of Directors or Certain Officers
5:28pm
8-K
EX-99.1
and8mhw8
11 Sep 23
Regulation FD Disclosure
8:01am
424B3
wjwy8shfhcmgy8oelk
22 Aug 23
Prospectus supplement
7:13pm
POS AM
4gad ztsha8o
18 Aug 23
Prospectus update (post-effective amendment)
4:07pm
424B3
ugr9v
11 Aug 23
Prospectus supplement
9:09am
424B3
7qnd31a
21 Apr 23
Prospectus supplement
4:18pm
POS AM
qqpa 77zm6kpmvn
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
ndc3e9b9gfcp
9 Sep 22
Prospectus supplement
5:05pm